Flagship explainer
How Vir Biotechnology, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $68.6M | 100% |
| |
| Cost of revenue | $26000 | 0% |
|
| $68.5M | 100% |
| |
| −$479M | −699% |
| |
| Income before tax | −$438M | −639% |
|
| Income tax | $217000 | 0% |
|
| −$438M | −639% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001628280-26-010749